EUVIMEDEUVIMED entdecken
Crossref

GDF15 increases insulin action in the liver and adipose tissue via a β-adrenergic receptor-mediated mechanism

Kim A Sjøberg, Casper M Sigvardsen, Abdiel Alvarado-Diaz, Nicoline Resen Andersen, Mark Larance, Randy J Seeley, Peter Schjerling, Jakob G Knudsen, Georgios Katzilieris-Petras, Christoffer Clemmensen, Sebastian Beck Jørgensen, Katrien De Bock und 1 weitere

Cell Metabolism · 2023-08 · 35 (8) · 1327-1340.e5

DOI: 10.1016/j.cmet.2023.06.016 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Metabolism, 2023-08. Verfasst von Kim A Sjøberg und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nutrition, Exercise, and Sports, Faculty of Science, University of Copenhagen, Copenhagen, Denmark. Hauptthemen laut MEDLINE: Receptors, Adrenergic, beta, Insulin Resistance. Die Arbeit wurde bisher 99-mal zitiert (Crossref) und nennt 57 Literaturangaben. Gefördert von: Eli Lilly and Company, Novo Nordisk Fonden, Novo Nordisk.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Growth differentiation factor 15 (GDF15) induces weight loss and increases insulin action in obese rodents. Whether and how GDF15 improves insulin action without weight loss is unknown. Obese rats were treated with GDF15 and displayed increased insulin tolerance 5 h later. Lean and obese female and male mice were treated with GDF15 on days 1, 3, and 5 without weight loss and displayed increased insulin sensitivity during a euglycemic hyperinsulinemic clamp on day 6 due to enhanced suppression of endogenous glucose production and increased glucose uptake in WAT and BAT. GDF15 also reduced glucagon levels during clamp independently of the GFRAL receptor. The insulin-sensitizing effect of GDF15 was completely abrogated in GFRAL KO mice and also by treatment with the β-adrenergic antagonist propranolol and in β1,β2-adrenergic receptor KO mice. GDF15 activation of the GFRAL receptor increases β-adrenergic signaling, in turn, improving insulin action in the liver and white and brown adipose tissue.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, Adrenergic, betaInsulin ResistanceMiceRatsMaleFemaleAnimalsGrowth Differentiation Factor 15ObesityAdipose TissueWeight LossInsulinAdipose Tissue, BrownLiver

Stichwörter der Autor:innen

GFRAL receptoradrenergic receptorsappetite controleuglycemic clampglucagonglucose metabolisminsulin resistanceinsulin sensitivity

Substanzen

Receptors, Adrenergic, betaGrowth Differentiation Factor 15Insulin

Autor:innen und Institutionen

  • Department of Nutrition, Exercise, and Sports, Faculty of Science, University of Copenhagen, Copenhagen, Denmark.
  • Laboratory of Exercise and Health, Department of Health Sciences and Technology, Swiss Federal Institute of Technology (ETH Zürich), Zurich, Switzerland.
  • Faculty of Medicine and Health, School of Medical Sciences, Charles Perkins Centre, University of Sydney, Sydney, Australia.
  • Department of Surgery, University of Michigan, Ann Arbor, MI, USA.
  • Institute of Sports Medicine Copenhagen, Department of Orthopedic Surgery, Copenhagen University Hospital - Bispebjerg and Frederiksberg, Copenhagen, Denmark; Center for Healthy Aging, Department of Biomedical Sciences,…
  • Section for Cell Biology and Physiology, Department of Biology, University of Copenhagen, Copenhagen, Denmark.

Förderung

  • Eli Lilly and Company
  • Novo Nordisk Fonden
  • Novo Nordisk
  • Lundbeck Foundation

Zitieren

APA

Sjøberg, K. A., Sigvardsen, C. M., Alvarado-Diaz, A., Andersen, N. R., Larance, M., Seeley, R. J., Schjerling, P., Knudsen, J. G., Katzilieris-Petras, G., Clemmensen, C., Jørgensen, S. B., De Bock, K., & Richter, E. A. (2023). GDF15 increases insulin action in the liver and adipose tissue via a β-adrenergic receptor-mediated mechanism. Cell Metabolism, 35(8), 1327-1340.e5. https://doi.org/10.1016/j.cmet.2023.06.016

Vancouver

Sjøberg KA, Sigvardsen CM, Alvarado-Diaz A, Andersen NR, Larance M, Seeley RJ, et al. GDF15 increases insulin action in the liver and adipose tissue via a β-adrenergic receptor-mediated mechanism. Cell Metabolism. 2023;35(8):1327-1340.e5. doi:10.1016/j.cmet.2023.06.016

BibTeX
@article{Sjberg2023,
  author = {Sjøberg, Kim A and Sigvardsen, Casper M and Alvarado-Diaz, Abdiel and Andersen, Nicoline Resen and Larance, Mark and Seeley, Randy J and Schjerling, Peter and Knudsen, Jakob G and Katzilieris-Petras, Georgios and Clemmensen, Christoffer and Jørgensen, Sebastian Beck and De Bock, Katrien and Richter, Erik A},
  title = {GDF15 increases insulin action in the liver and adipose tissue via a β-adrenergic receptor-mediated mechanism},
  journal = {Cell Metabolism},
  year = {2023},
  volume = {35},
  number = {8},
  pages = {1327--1340.e5},
  doi = {10.1016/j.cmet.2023.06.016}
}
Kostenlos starten →